Showing results (111-120 of 643) with videos related to

Sort By:
Pageof 65
Journal of Clinical Pathology|July 1, 1984
Detection of toxin production by Corynebacterium diphtheriae: results of a trial organised as part of the United Kingdom National External Microbiological Quality Assessment SchemeJ J Snell, J V Demello, P S Gardner, et al.
Infectious Disease Clinics of North America|December 15, 2019
Collaborative Antimicrobial Stewardship: Working with Hospital and Health System AdministrationWhitney R Buckel, Keith S Kaye, Payal K Patel
Journal of Personality Disorders|July 14, 1998
Factor structure of psychopathy among methadone maintenance patientsS Darke, S Kaye, R Finlay-Jones, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2018
Ceftazidime/Avibactam, Meropenem/Vaborbactam, or Both? Clinical and Formulary ConsiderationsJason M Pogue, Robert A Bonomo, Keith S Kaye
Audiology : Official Organ of the International Society of Audiology|January 1, 1985
Response threshold determination of the brain stem auditory evoked response: a comparison of the phase versus magnitude derived from the fast Fourier transformE Greenblatt, R A Zappulla, S Kaye, et al.
Expert Review of Anti-Infective Therapy|October 30, 2018
Meropenem-vaborbactam for adults with complicated urinary tract and other invasive infectionsOwen R Albin, Twisha S Patel, Keith S Kaye
Journal of Forensic Sciences|January 1, 1990
Families, murder, and insanity: a psychiatric review of paternal neonaticideN S Kaye, N M Borenstein, S M Donnelly
Drug and Alcohol Review|September 1, 1996
Anti-social personality disorder and response to methadone maintenance treatmentS Darke, R Finlay-Jones, S Kaye, et al.
American Journal of Clinical Oncology|February 1, 1997
Aortic wall sarcoma with tumor emboli and peripheral ischemia: case report with review of literatureA Khan, F Jilani, S Kaye, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 28, 2017
Clinical considerations for optimal use of the polymyxins: A focus on agent selection and dosingJ M Pogue, J K Ortwine, K S Kaye
Pageof 65